Penthrox® entered in the European Society of Emergency Medicine (“EUSEM”) guidelines as now being recommended and approved as “first-line of treatment”
Medical Developments International Ltd (ASX: MVP) is delighted to announce that Penthrox has been
included in the new EUSEM guidelines for the “Management of acute pain in emergency situations”. These new guidelines are published on the EUSEM website and can be found
at: https://eusem.org/education/guidelines. The Guidelines cover all aspects of acute pain management in emergency situations across Europe.
Inclusion in these guidelines is a pivotal moment for Penthrox which is now a “first-line of treatment” option in both moderate and severe pain.
Clinical study data contained in the InMEDIATE and MEDITA studies is included within the guidelines providing clinical evidence supporting the Penthrox use. The Guidelines were sponsored financially by an educational grant from Mundipharma International Limited who had no editorial input.
Be the first to comment